Yesterday, Joel Sherman and Ken Davidoff of the New York Post reported "the strong indications are Major League Baseball will announce all the suspensions in the Biogenesis case this week." No announcement from MLB is expected today, tweets Steven Marcus of Newsday. Wednesday's trade deadline is "no factor when it comes to the timing of announcements related to the case," hears Jon Heyman of CBS Sports. We could be in for a wild week. The latest on Biogenesis:
- MLB is willing to offer Rodriguez a suspension of the rest of this year and all of 2014, report Bill Madden, Teri Thompson, and Michael O'Keefe of the New York Daily News, and if he declines, MLB is expected to attempt to ban him for life. Over at River Ave. Blues, Mike Axisa runs through different scenarios involving A-Rod.
- The Yankees have continued to search for third base help, but Heyman says that isn't necessarily tied to the possibility A-Rod gets suspended. Though first-time offenders are permitted to play during an appeals process, baseball might challenge that practice in the case of Rodriguez, writes Rosenthal.
- The Tigers have shown no indication they are looking for a shortstop replacement, writes Heyman. "I would think Detroit would want a shortstop, but we'll see," an NL GM told Heyman. Neither Peralta nor Nelson Cruz has indicated to his team a plan in case of a suspension, writes Yahoo's Jeff Passan. It's possible those two will be faced with choosing their current team (appealing a suspension into next year) or choosing to preserve their free agent value (serving a 50-game suspension now). I imagine taking what might be perceived as the selfish route, serving the suspension now, could hurt free agent stock in its own right.
- As you might expect, the Rangers prefer a prolonged appeals process for Cruz, writes Bob Nightengale of USA Today. Nightengale wonders, "If Cruz goes down without a fight and accepts his penalty, why would they want a guy back who quit on the organization?" That question would apply to Cruz potentially returning for the playoffs, as well as signing a new deal with the Rangers in the offseason. Cruz might have to settle for a less lucrative two-year free agent deal similar to that of Melky Cabrera, one GM estimated to Heyman.
- Since Colon already completed a 50-game suspension for PED use, A's people are expressing confidence he won't get another suspension, writes Heyman, and Ken Rosenthal of FOX Sports also hears the same. The team's pursuit of Jake Peavy is unrelated.
- "If drug dealers can use the currency of player evidence as a means to gain immunity and even more money, then our system of policing and protecting baseball has incentivized the people and the very behavior that was the genesis of the problem," agent Scott Boras tells Rosenthal. Baseball cut a deal with Biogenesis owner Anthony Bosch that provides many protections.
- In dealing with Jason Giambi, the Yankees concluded they cannot void a contract based on PED use, writes ESPN's Buster Olney. Some lawyers, however, wonder if a team could file a lawsuit against a player alleging damage to their brand.